Tag Archives: Medicines for Malaria Venture

GlaxoSmithKline and Medicines for Malaria Venture start phase III global programme of tafenoquine for the treatment of Plasmodium vivax malaria

London, 29-4-2014 — /EuropaWire/ — GlaxoSmithKline (GSK) and Medicines for Malaria Venture (MMV) today announced the start of a phase III global programme to evaluate the efficacy and safety of tafenoquine, an investigational medicine which is being developed for the treatment and … Read the full press release